Cannabis Re-Scheduling: Commercial Lending Implications

The federal government's long-anticipated shift in how cannabis is treated is moving forward, with re-scheduling now a real possibility, for banks and credit unions serving or considering cannabis-related businesses (CRBs), the implications are significant.

Join Chris Van Dyck, Partner at Cogent Law, for a practical, one-hour discussion on cannabis re-scheduling and what it is likely to mean for commercial lending, compliance, and competitive positioning. This session will focus on how financial institutions can stay compliant while identifying new revenue opportunities as regulatory frameworks evolve.

Chris will break down what's changing, what isn't, and how institutions should be preparing now as re-scheduling moves ahead.

Detailed Topics

• Cannabis Re-Scheduling Overview
  • A deep dive into the re-scheduling executive order
  • How the process is expected to unfold, including timing and procedural considerations
• Commercial Lending Implications
  • What re-scheduling may mean for lending to cannabis-related businesses
  • Key underwriting, collateral, and structural considerations
  • Evaluating potential new revenue streams tied to cannabis lending
• BSA/AML & Compliance Impacts
  • What may change, what won't, and examiner expectations
  • Implications for cannabis-related compliance programs
• Risk Framework Updates
  • Re-evaluating enterprise risk and cannabis program risk assessments
  • Updates to policies, procedures, and internal controls
• Customer & Member Communications
  • What financial institutions should be telling cannabis customers now
  • Managing expectations and strengthening customer relationships
• Business Services & Competition
  • Treasury and cash management considerations
  • Onboarding and product positioning
  • How to compete effectively as more institutions enter the cannabis and hemp banking space